A detailed history of My.Alpha Management Hk Advisors LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, My.Alpha Management Hk Advisors LTD holds 69,762 shares of BGNE stock, worth $12.3 Million. This represents 6.66% of its overall portfolio holdings.

Number of Shares
69,762
Holding current value
$12.3 Million
% of portfolio
6.66%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$143.93 - $224.51 $10 Million - $15.7 Million
69,762 New
69,762 $15.7 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.3B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track My.Alpha Management Hk Advisors LTD Portfolio

Follow My.Alpha Management Hk Advisors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of My.Alpha Management Hk Advisors LTD, based on Form 13F filings with the SEC.

News

Stay updated on My.Alpha Management Hk Advisors LTD with notifications on news.